← Contracts
PT
Aquisição de Anacinra 100 mg/0.67 ml sol inj ser 0.67 ml SC, Bussulfano 60 mg/10 ml sol inj fr 10 ml IV, Fluorouracilo 50 mg/ml sol inj fr 100 ml IA IV, Interferão Beta-1A (Avonex seringas) 6 M.U.I. pó sol inj fr IM, Lenvatinib 10 mg cáps (Lenvima), Leuprorrelina 45 mg pó sol inj ser SC, Ramucirumab 10 mg/ml sol inj fr 50 ml IV e Vinorrelbina 20 mg cáps
ID 11371892
· Portal BASE
Price
Base Price
€71,770
.00
Effective Price
€3,118
.00
-95.7%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
LILLY-PORTUGAL PRODUTOS FARMACÊUTICOS LDA
NIF 500165602
Dates
- Publication
- 25 Apr 2025
- Celebration
- 01 Apr 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 85 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 25 Apr 2025
- Signing Date
- 01 Apr 2025
- Days Late
- 24
- Rule
- A2/A3 late publication: 24 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
- Base price
- 71770.0
- Threshold
- 75000.0
- Rule
- A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 71770.0
- Total effective price
- 3118.0
- Ratio
- 0.0434
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0434 outside [0.5, 1.5]
Detected 2026-03-06